The Ultrasound 2 (USND 2) system is the next generation device which has replaced the existing Ultrasound system onboard the ISS. The new system is being used on the ISS in support of the Human Research Program’s (HRP) International Space Station Medical Project (ISSMP) and medical operations.

NASA launched the Ultrasound-2 system aboard STS 135, Atlantis on July 8, 2011 to support biomedical investigations and to provide medical monitoring of the astronauts onboard the International Space Station.

Similar to the devices used in medical care on the ground, the system is a diagnostic tool that provides images of internal organs and muscles. The Ultrasound 2 system includes a commercially developed ultrasound device (General Electric Medical Systems, Vivid-q™) that was modified for spaceflight, as well as a custom built external video/power converter assembly. The Ultrasound-2 system will replace the device onboard ISS that is no longer functioning.

This system was developed as part of the Human Research Program’s ISS Medical Project, which provides a suite of science instruments used to study and solve the human health and performance challenges and the risks associated with exploration missions.

The project team which supported this effort was lead by the Space Biosciences Division Flight Systems Implementation Branch located at Ames Research Center.

Project Manager:  David L. Pletcher, NASA, ARC
Deputy Project Manager:  Tianna Shaw, NASA, ARC
Systems Engineer:  Julie Levri, NASA, ARC

The Ultrasound 2 is on-orbit and being used by crew members performing biomedical and human research experiment operations.  Read more

http://www.nasa.gov/mission_pages/station/research/news/Ultrasound_2.html

http://satellite.tmcnet.com/topics/satellite/articles/194194-ge-telemedi...